Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03884660 · ClinicalTrials.gov registry record
remedē System Therapy Study
A clinical trial of Central Sleep Apnea, sponsored by Respicardia.
- Active
- Registry status
- 225
- Enrollment target
- 20
- Study locations
NCT03884660 is a study of Central Sleep Apnea that is active but no longer recruiting, run by Respicardia. The registered enrollment target is 225 participants, above the 94-participant average among 4 other Central Sleep Apnea trials with a reported enrollment target (139% higher). The trial reports 20 study locations across 14 states.
The verdict
NCT03884660, a study of Central Sleep Apnea, is active but no longer recruiting, sponsored by Respicardia.
- ACTIVE NOT RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.
Conditions Studied
Interventions
- DEVICE remede System
Study Locations (20)
Arizona
- Banner University Medical Center - Phoenix
- Arizona Heart Rhythm Center - Phoenix
- HonorHealth - Scottsdale
North Carolina
- Novant Health - Charlotte - Charlotte
- East Carolina University - Greenville
- Novant Health Forsyth Medical Center - Winston-Salem
Colorado
- University of Colorado- Anschutz - Aurora
- University of Colorado Health - Fort Collins
New York
- Northwell Health - New Hyde Park
- New York Presbyterian Hospital-Weill Cornell Medicine - New York
California
- The University of California San Francisco - San Francisco
Florida
- Central Florida Pulmonary Group - Orlando
Georgia
- Emory University Midtown Hospital - Atlanta
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2019-06-18 |
| Est. Completion | 2030-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03884660
The ClinicalTrials.gov registry entry for NCT03884660 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 94-participant average among 4 other Central Sleep Apnea trials with a reported enrollment target (139% higher). The listed sponsor is Respicardia, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Central Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which remede System is the first listed.
NCT03884660 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Arizona, North Carolina, Colorado.
Frequently Asked Questions
What is clinical trial NCT03884660 about?
NCT03884660 is a clinical study titled "remedē System Therapy Study". The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.
What is the current status of trial NCT03884660?
This trial is currently active not recruiting. The enrollment target is 225 participants. The study started on 2019-06-18. Estimated completion is 2030-12-30.
What conditions does trial NCT03884660 study?
This clinical trial studies the following conditions: Central Sleep Apnea.
What interventions are being tested in trial NCT03884660?
The interventions under investigation include: remede System (DEVICE).
Who is sponsoring clinical trial NCT03884660?
This trial is sponsored by Respicardia, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03884660 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.